INO
Inovio Pharmaceuticals Inc
Price:  
9.45 
USD
Volume:  
134,472.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO WACC - Weighted Average Cost of Capital

The WACC of Inovio Pharmaceuticals Inc (INO) is 8.0%.

The Cost of Equity of Inovio Pharmaceuticals Inc (INO) is 8.15%.
The Cost of Debt of Inovio Pharmaceuticals Inc (INO) is 6.65%.

Range Selected
Cost of equity 6.90% - 9.40% 8.15%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.8% - 9.2% 8.0%
WACC

INO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.82
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.07 0.07
Cost of debt 6.30% 7.00%
After-tax WACC 6.8% 9.2%
Selected WACC 8.0%